These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 34677358)
21. Magnetic Fe3O4@Au composite-enhanced surface plasmon resonance for ultrasensitive detection of magnetic nanoparticle-enriched α-fetoprotein. Liang RP; Yao GH; Fan LX; Qiu JD Anal Chim Acta; 2012 Aug; 737():22-8. PubMed ID: 22769032 [TBL] [Abstract][Full Text] [Related]
22. Distinct Autoimmune Anti-α-Synuclein Antibody Patterns in Multiple System Atrophy and Parkinson's Disease. Folke J; Rydbirk R; Løkkegaard A; Salvesen L; Hejl AM; Starhof C; Bech S; Winge K; Christensen S; Pedersen LØ; Aznar S; Pakkenberg B; Brudek T Front Immunol; 2019; 10():2253. PubMed ID: 31616427 [TBL] [Abstract][Full Text] [Related]
23. Surface Plasmon Resonance Sensor Based on Core-Shell Fe Fan L; Du B; Pei F; Hu W; Guo A; Xie Z; Liu B; Tong Z; Mu X; Tan W Sensors (Basel); 2023 Mar; 23(6):. PubMed ID: 36991789 [TBL] [Abstract][Full Text] [Related]
24. A longitudinal study on α-synuclein in plasma neuronal exosomes as a biomarker for Parkinson's disease development and progression. Niu M; Li Y; Li G; Zhou L; Luo N; Yao M; Kang W; Liu J Eur J Neurol; 2020 Jun; 27(6):967-974. PubMed ID: 32150777 [TBL] [Abstract][Full Text] [Related]
25. Decrease in plasma levels of α-synuclein is evident in patients with Parkinson's disease after elimination of heterophilic antibody interference. Ishii R; Tokuda T; Tatebe H; Ohmichi T; Kasai T; Nakagawa M; Mizuno T; El-Agnaf OM PLoS One; 2015; 10(4):e0123162. PubMed ID: 25849645 [TBL] [Abstract][Full Text] [Related]
26. Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease. El-Agnaf OM; Salem SA; Paleologou KE; Curran MD; Gibson MJ; Court JA; Schlossmacher MG; Allsop D FASEB J; 2006 Mar; 20(3):419-25. PubMed ID: 16507759 [TBL] [Abstract][Full Text] [Related]
27. A Comparative Study of the Diagnostic Potential of Plasma and Erythrocytic α-Synuclein in Parkinson's Disease. Wang L; Wang G; Duan Y; Wang F; Lin S; Zhang F; Li H; Li A; Li H Neurodegener Dis; 2019; 19(5-6):204-210. PubMed ID: 32485710 [TBL] [Abstract][Full Text] [Related]
28. Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease. Majbour NK; Vaikath NN; van Dijk KD; Ardah MT; Varghese S; Vesterager LB; Montezinho LP; Poole S; Safieh-Garabedian B; Tokuda T; Teunissen CE; Berendse HW; van de Berg WD; El-Agnaf OM Mol Neurodegener; 2016 Jan; 11():7. PubMed ID: 26782965 [TBL] [Abstract][Full Text] [Related]
29. A label-free ultrasensitive microfluidic surface Plasmon resonance biosensor for Aflatoxin B Bhardwaj H; Sumana G; Marquette CA Food Chem; 2020 Mar; 307():125530. PubMed ID: 31639579 [TBL] [Abstract][Full Text] [Related]
30. Studies of gold nanorod-iron oxide nanohybrids for immunoassay based on SPR biosensor. Zhang H; Sun Y; Gao S; Zhang H; Zhang J; Bai Y; Song D Talanta; 2014 Jul; 125():29-35. PubMed ID: 24840411 [TBL] [Abstract][Full Text] [Related]
31. Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson's disease. Wang X; Yu S; Li F; Feng T Neurosci Lett; 2015 Jul; 599():115-9. PubMed ID: 25998655 [TBL] [Abstract][Full Text] [Related]
32. An innovative transportable immune device for the recognition of α-synuclein using KCC-1- Saadati A; Baghban HN; Hasanzadeh M; Shadjou N RSC Adv; 2024 Mar; 14(13):8810-8818. PubMed ID: 38495975 [TBL] [Abstract][Full Text] [Related]
33. Alpha-Synuclein as a Biomarker for Parkinson's Disease. Atik A; Stewart T; Zhang J Brain Pathol; 2016 May; 26(3):410-8. PubMed ID: 26940058 [TBL] [Abstract][Full Text] [Related]
34. Naturally occurring alpha-synuclein autoantibodies in Parkinson's disease: sources of (error) variance in biomarker assays. Heinzel S; Gold M; Deuschle C; Bernhard F; Maetzler W; Berg D; Dodel R PLoS One; 2014; 9(12):e114566. PubMed ID: 25470145 [TBL] [Abstract][Full Text] [Related]
35. Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease. Foulds PG; Mitchell JD; Parker A; Turner R; Green G; Diggle P; Hasegawa M; Taylor M; Mann D; Allsop D FASEB J; 2011 Dec; 25(12):4127-37. PubMed ID: 21865317 [TBL] [Abstract][Full Text] [Related]
36. An innovative method for the detection of alpha synuclein, a potential biomarker of Parkinson's disease: quartz tuning fork-based mass sensitive immunosensor design. Sonuç Karaboğa MN; Ünal MA; Arı F; Sezgintürk MK; Özkan SA Phys Chem Chem Phys; 2024 Feb; 26(6):5106-5114. PubMed ID: 38259152 [TBL] [Abstract][Full Text] [Related]
37. A novel, label-free liquid crystal biosensor for Parkinson's disease related alpha-synuclein. Yang X; Li H; Zhao X; Liao W; Zhang CX; Yang Z Chem Commun (Camb); 2020 May; 56(40):5441-5444. PubMed ID: 32292959 [TBL] [Abstract][Full Text] [Related]
38. SPR immunosensor combined with Ti Yin Z; Cheng X; Wang G; Chen J; Jin Y; Tu Q; Xiang J Mikrochim Acta; 2020 Aug; 187(9):509. PubMed ID: 32833087 [TBL] [Abstract][Full Text] [Related]
39. Aptamer/thrombin/aptamer-AuNPs sandwich enhanced surface plasmon resonance sensor for the detection of subnanomolar thrombin. Bai Y; Feng F; Zhao L; Wang C; Wang H; Tian M; Qin J; Duan Y; He X Biosens Bioelectron; 2013 Sep; 47():265-70. PubMed ID: 23584389 [TBL] [Abstract][Full Text] [Related]